trending Market Intelligence /marketintelligence/en/news-insights/trending/k_fxluqe1xq43ezypdpz8a2 content
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

In This List

Sienna Cancer Diagnostics adds board director

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

The Market Intelligence Platform


Sienna Cancer Diagnostics adds board director

Sienna Cancer Diagnostics Ltd. named Helen Fisher an independent nonexecutive director, effective March 28.

Fisher will also act as chair of the company's audit and risk committee. She was a partner at Deloitte and adviser to several life sciences and biotechnology companies, Sienna Cancer Diagnostics said in a news release.

Australia-based Sienna Cancer is a medical technology company developing and marketing innovative cancer related tests, with operations in the U.S. and Europe.